New FDA program incentivizes drugmakers to invest in quality measures
Quality issues are still the number one reason for drug shortages, and in an effort to address this, the U.S. Food and Drug Administration is debuting a quality management maturity (QMM) program intended to incentivize drugmakers to invest in quality measures. The program will be run by the FDA’s Center for Drug Evaluation and Research…